Related Experiment Video
Updated: Feb 9, 2026

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
Human Kinase/Phosphatase-Wide RNAi Screening Identified Checkpoint Kinase 2 as a Cellular Factor Facilitating
Yi-Lin Chan1,2, Ching-Len Liao3,4, Yi-Ling Lin2,3,5
1Department of Life Science, Chinese Culture University, Taipei, Taiwan.
Abstract:
Japanese encephalitis virus (JEV), a mosquito-borne flavivirus, causes acute encephalitis in humans with high mortality. Not much is known about the interactions between viral and cellular factors that regulate JEV infection. By using a kinase/phosphatase-wide RNAi screening approach, we identified a cell cycle-regulating molecule, checkpoint kinase 2 (CHK2), that plays a role in regulating JEV replication. JEV infection induced G1 arrest and activated CHK2. Inactivation of CHK2 and its upstream ataxia-telangiectasia mutated kinase in JEV-infected cells by using inhibitors reduced virus replication. Likewise, JEV replication was significantly decreased by knockdown of CHK2 expression with shRNA-producing lentiviral transduction. We identified CHK2 as a cellular factor participating in JEV replication, for a new strategy in addressing JEV infection.
Insights
Japanese encephalitis virus (JEV) activates checkpoint kinase 2 (CHK2), a cell cycle regulator. Inhibiting CHK2 reduces JEV replication, offering a new strategy against this dangerous flavivirus.
Area of Science:
- Virology
- Cell Biology
- Molecular Biology
Background:
- Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus causing severe human encephalitis and high mortality.
- Understanding the interplay between viral and host cellular factors is crucial for controlling JEV infection.
Purpose of the Study:
- To identify cellular factors regulating Japanese encephalitis virus replication.
- To investigate the role of cell cycle regulators in JEV infection.
Main Methods:
- Utilized a kinase/phosphatase-wide RNA interference (RNAi) screening approach.
- Employed chemical inhibitors to inactivate CHK2 and ATM kinases.
- Used shRNA-producing lentiviral transduction to knockdown CHK2 expression.
Main Results:
- Identified checkpoint kinase 2 (CHK2), a cell cycle regulator, as a key factor in JEV replication.
- Observed that JEV infection induces G1 cell cycle arrest and activates CHK2.
- Demonstrated that inactivation or knockdown of CHK2 significantly reduces JEV replication.
Conclusions:
- Checkpoint kinase 2 (CHK2) is a critical cellular factor that participates in and promotes Japanese encephalitis virus replication.
- Targeting CHK2 presents a potential novel therapeutic strategy for managing JEV infections.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Receptor Tyrosine Kinases
cAMP-dependent Protein Kinase Pathways
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Transcription Factors

